FindMyKOL
Clinical trialNCT06482957RecruitingObservational

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

SponsorVanderbilt-Ingram Cancer CenterEnrollment2,100Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Vanderbilt University/ingram Cancer Center

    Nashville, Tennessee, United States

    Debra Friedman, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2022
Primary completion
30 Apr 2028
Completion
30 Apr 2029
Last update posted
19 Sept 2025
Registered enrollment
2,100
Registry id
NCT06482957
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.